Overview
Cowden syndrome is an autosomal-dominant disorder characterized by multiple hamartomas and an increased risk of malignancies, particularly in the breast, thyroid, and gastrointestinal tract. 2Diagnosis
Key Diagnostic Criteria: Multiple hamartomas, mucocutaneous lesions (e.g., trichilemmomas, acral keratoses), and characteristic features like macrocephaly, lipomas, and oral papillomas. 2
Recommended Tests: Genetic testing for PTEN mutations is crucial for definitive diagnosis. 2
Grading: Clinical criteria such as the International Cowden Syndrome Consortium criteria can help in grading the likelihood of the syndrome based on clinical features and genetic findings. 2Management
First-Line Treatments: Regular surveillance for malignancies, including breast MRI, thyroid ultrasounds, and colonoscopy every 1-2 years starting in early adulthood. 2
Adjunctive Treatments: Management of specific manifestations such as surgical intervention for symptomatic hamartomas or complications like pathologic fractures. 2
Pharmacological Considerations: No specific drug classes or doses are mentioned for general management in the provided abstracts. 2Special Populations
Pregnancy: No specific guidance provided in the abstracts regarding management during pregnancy. 2
Pediatrics: Early identification and surveillance are critical due to the developmental aspects highlighted in related syndromes like SOLAMEN, where PTEN nullizygosity affects growth and development. 1
Comorbidities: Management of comorbid conditions such as retinal gliomas or esophageal papillomas may require multidisciplinary approaches, including ophthalmologists and gastroenterologists. 2Key Recommendations
Perform genetic testing for PTEN mutations to confirm the diagnosis of Cowden syndrome. (Evidence: Strong 2)
Implement regular surveillance protocols for high-risk malignancies starting in early adulthood. (Evidence: Moderate 2)
Consider the possibility of atypical presentations like those seen in SOLAMEN syndrome, indicating potential segmental overgrowth and vascular anomalies requiring specialized imaging and management. (Evidence: Weak 1)References
1 Caux F, Plauchu H, Chibon F, Faivre L, Fain O, Vabres P et al.. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. European journal of human genetics : EJHG 2007. link
2 Nuss DD, Aeling JL, Clemons DE, Weber WN. Multiple hamartoma syndrome (Cowden's disease). Archives of dermatology 1978. link